Xspray Pharma: Raising SEK83m - Redeye
Bildkälla: Stockfoto

Xspray Pharma: Raising SEK83m - Redeye

Yesterday's rights issue announcement aligned closely to the scenario we discussed in our previous research update. The dilution is relatively limited at 9-11%, compared to our estimate of 10%. With the cash raise out of the way, the two upcoming PDUFA dates is likely to start monopolizing the markets attention.

Yesterday's rights issue announcement aligned closely to the scenario we discussed in our previous research update. The dilution is relatively limited at 9-11%, compared to our estimate of 10%. With the cash raise out of the way, the two upcoming PDUFA dates is likely to start monopolizing the markets attention.
Börsvärldens nyhetsbrev